208 related articles for article (PubMed ID: 9669654)
21. 5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial.
Tsavaris NB; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekois D; Tsetis A; Klonaris C
Am J Clin Oncol; 1996 Oct; 19(5):517-21. PubMed ID: 8823483
[TBL] [Abstract][Full Text] [Related]
22. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
Felici A; Carlini P; Ruggeri EM; Gamucci T; Pollera CF; De Marco S; Fariello AM; Moscetti L; Gelibter A; Adami E; Sperduti I; Cognetti F
Cancer Chemother Pharmacol; 2006 Jan; 57(1):59-64. PubMed ID: 16001173
[TBL] [Abstract][Full Text] [Related]
23. Weekly oxaliplatin, high-dose infusional 5-fluorouracil and folinic acid as palliative third-line therapy of advanced colorectal carcinoma.
Kallen KJ; Hofmann MA; Timm A; Gödderz W; Galle PR; Heike M
Z Gastroenterol; 2000 Feb; 38(2):153-7. PubMed ID: 10721170
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277
[TBL] [Abstract][Full Text] [Related]
25. High dose folinic acid and 5-fluorouracil bolus and continuous infusion for patients with advanced colorectal cancer.
Bécouarn YH; Brunet RC; Rouhier ML; Bussières EJ; Avril AR; Richaud PM; Dilhuydy JM
Cancer; 1995 Oct; 76(7):1126-31. PubMed ID: 8630887
[TBL] [Abstract][Full Text] [Related]
26. Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: a phase II study.
Bertuccelli M; Falcone A; Campoccia S; Conti M; Brunetti I; Caramella D; Giulianotti PC; Mosca F; Bartolozzi C; Conte PF
Tumori; 1999; 85(6):473-7. PubMed ID: 10774568
[TBL] [Abstract][Full Text] [Related]
27. [Tolerance of adjuvant treatment combining postoperative intraportal chemotherapy and a systemic treatment based on 5-fluorouracil in colorectal carcinoma with a histologically poor prognosis].
Longree L; Focan C; Dallemagne B; Delforge M; Jehaes C; Malherbe R; Mazy V; Markiewicz S; Weerts J; Lombard R
Acta Gastroenterol Belg; 1992; 55(4):341-9. PubMed ID: 1462746
[TBL] [Abstract][Full Text] [Related]
28. Fluorouracil combined with the pure (6S)-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study.
Machover D; Grison X; Goldschmidt E; Zittoun J; Lotz JP; Metzger G; Richaud J; Hannoun L; Marquet J; Guillot T
J Natl Cancer Inst; 1992 Mar; 84(5):321-7. PubMed ID: 1738182
[TBL] [Abstract][Full Text] [Related]
29. Combined systemic chronotherapy and hepatic artery infusion for the treatment of metastatic colorectal cancer confined to the liver.
Shimonov M; Hayat H; Chaitchik S; Brener J; Schachter P; Czerniak A
Chemotherapy; 2005 May; 51(2-3):111-5. PubMed ID: 15886466
[TBL] [Abstract][Full Text] [Related]
30. 5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens.
Machover D; Grison X; Goldschmidt E; Zittoun J; Metzger G; Richaud J; Lotz JP; André T; Hannoun L; Marquet J
Ann Oncol; 1993; 4 Suppl 2():29-35. PubMed ID: 8353102
[TBL] [Abstract][Full Text] [Related]
31. Mitomycin C and high-dose 5-fluorouracil with folinic acid as a therapeutic option for heavily pretreated patients with metastatic colorectal cancer: prospective phase II trial.
Stec R; Bodnar L; Smoter M; Korniluk J; Kuchar A; Młot B; Szczylik C
Oncologist; 2014 Apr; 19(4):356-7. PubMed ID: 24682464
[TBL] [Abstract][Full Text] [Related]
32. A phase II study of irinotecan, high-dose 24-h continuous intravenous infusion of floxuridine and leucovorin (IFLUX) for advanced, previously untreated colorectal cancer.
Ardalan B; Kozyreva O; Tsai KT; Santos E; Franceschi D; Livingstone A; Lima M
Anticancer Drugs; 2007 Sep; 18(8):955-61. PubMed ID: 17667602
[TBL] [Abstract][Full Text] [Related]
33. Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.
Hartmann JT; Pintoffl JP; Al-Batran SE; Quietzsch D; Meisinger I; Horger M; Nehls O; Bokemeyer C; Königsrainer A; Jäger E; Kanz L
Onkologie; 2007 May; 30(5):235-40. PubMed ID: 17460417
[TBL] [Abstract][Full Text] [Related]
34. 5-Fluorouracil, high-dose folinic acid, and mitomycin C combination chemotherapy in advanced gastrointestinal adenocarcinomas. A pilot study.
Becouarn Y; Brunet R; Bussières E; Marée D
Oncology; 1988; 45(4):269-72. PubMed ID: 3133620
[TBL] [Abstract][Full Text] [Related]
35. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer: poor response rate in unselected patients.
Hanna CL; McKinna FE; Williams LB; Morrey D; Adams M; Mason MD; Maughan TS
Br J Cancer; 1995 Sep; 72(3):774-6. PubMed ID: 7669593
[TBL] [Abstract][Full Text] [Related]
36. Continuous 24-hour infusion of folinic acid does not increase the response rate of 5-fluorouracil but only the toxicity.
Tsavaris N; Tzannou I; Karvounis N; Kosmidis P
Oncology; 1992; 49(2):154-6. PubMed ID: 1574252
[TBL] [Abstract][Full Text] [Related]
37. Retrospective comparative analysis of 5FU + low-dose folinic acid vs. 5FU + high-dose folinic acid in the treatment of metastatic colorectal cancer. The Ottawa experience.
Maroun JA; Cripps C; Goel R; Dahrouge S; Boisvert D
Am J Clin Oncol; 1997 Aug; 20(4):387-92. PubMed ID: 9256896
[TBL] [Abstract][Full Text] [Related]
38. Weekly 24-hour infusion of high-dose 5-fluorouracil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancer.
Kretzschmar A; Reichardt P; Thuss-Patience PC; Hohenberger P; Benter T; Dörken B; Köhne CH
Oncology; 2000 Jun; 59(1):14-7. PubMed ID: 10895060
[TBL] [Abstract][Full Text] [Related]
39. Prospective phase II trial of iriontecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer.
Gil-Delgado MA; Guinet F; Castaing D; Adam R; Coeffic D; Durrani AK; Bismuth H; Khayat D
Am J Clin Oncol; 2001 Feb; 24(1):101-5. PubMed ID: 11232943
[TBL] [Abstract][Full Text] [Related]
40. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.
De Gramont A; Krulik M; Cady J; Lagadec B; Maisani JE; Loiseau JP; Grange JD; Gonzalez-Canali G; Demuynck B; Louvet C
Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1499-503. PubMed ID: 3263275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]